BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Wenjie Zheng, Min Yao, Qi Qian, Wenli Sai, Liwei Qiu, Junling Yang, Wei Wu, Zhizhen Dong, Dengfu Yao. Oncogenic secretory clusterin in hepatocellular carcinoma: Expression at early staging and emerging molecular targetOncotarget 2017; 8(32): 52321 doi: 10.18632/oncotarget.13674
2
Jeong Won Lee, Sang Hyun Hwang, Hyun Jeong Kim, Dongwoo Kim, Arthur Cho, Mijin Yun. Volumetric parameters on FDG PET can predict early intrahepatic recurrence-free survival in patients with hepatocellular carcinoma after curative surgical resectionEuropean Journal of Nuclear Medicine and Molecular Imaging 2017; 44(12): 1984 doi: 10.1007/s00259-017-3764-7
3
Cory Szybala, Mollie Parker Szybala, Peter B. Bongiorno. Textbook of Natural Medicine2020; : 1358 doi: 10.1016/B978-0-323-43044-9.00176-X
4
Issei Saeki, Takahiro Yamasaki, Masaki Maeda, Reo Kawano, Takuro Hisanaga, Takuya Iwamoto, Toshihiko Matsumoto, Isao Hidaka, Tsuyoshi Ishikawa, Taro Takami, Isao Sakaida. No Muscle Depletion with High Visceral Fat as a Novel Beneficial Biomarker of Sorafenib for Hepatocellular CarcinomaLiver Cancer 2018; 7(4): 359 doi: 10.1159/000487858
5
Hui Peng, Yingfei Wang, Weibo Luo. Multifaceted role of branched-chain amino acid metabolism in cancerOncogene 2020;  doi: 10.1038/s41388-020-01480-z
6
Wan-Shui Yang, Xu-Fen Zeng, Zhi-Ning Liu, Qi-Hong Zhao, Yu-Ting Tan, Jing Gao, Hong-Lan Li, Yong-Bing Xiang. Diet and liver cancer risk: a narrative review of epidemiological evidenceBritish Journal of Nutrition 2020; 124(3): 330 doi: 10.1017/S0007114520001208
7
Joshua P. Gray, Natalia Suhali-Amacher, Sidhartha D. Ray. A Worldwide Yearly Survey of New Data in Adverse Drug ReactionsSide Effects of Drugs Annual 2017; 39: 197 doi: 10.1016/bs.seda.2017.07.001